MFDS — authorised 28 May 2004
- Marketing authorisation holder: ALLERGAN
- Status: likely_approved
MFDS authorised Sanctura on 28 May 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 28 May 2004.
ALLERGAN holds the South Korean marketing authorisation.